Sponsored by

​FDA sets new date next month for hearing on Sarepta’s Duchenne drug

Nearly two months after the FDA postponed a committee hearing for a drug for Duchenne muscular dystrophy due to a snowstorm, this morning the agency finally announced a new date.

​Cambridge-based Vericel doubles in value on heart failure trial results

Today the company said a trial involving 114 patients met its main goal of reducing the number of deaths and hospitalizations in some of the most advanced heart failure patients.

Medtronic to close Mansfield building that once was Covidien's HQ

The company reportedly said it’s not related to any job cuts on the campus.

Medical community mobilizing against legalized marijuana in Massachusetts

The state's medical community is voicing strong opposition to recreational use of marijuana, formally speaking out for the first time this week against a statewide ballot campaign to legalize the drug.

SAN JOSE: Cisco’s chief people officer is ‘breaking HR’

Madrona Venture Labs adds top Seattle entreprenuers to new roster of advisers